CMS releases details on billing for expanded use of Moderna, J&J boosters

The Centers for Medicare & Medicaid Services Friday released Medicare Part B billing codes and payment allowances for reporting and administering single booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines to eligible adults as authorized Oct. 22 by the Food and Drug Administration.
Authorized COVID-19 booster doses are covered without cost sharing for eligible Medicare, Medicaid, Children's Health Insurance Program and commercial health plan beneficiaries, CMS said.
Related News Articles
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug…
Headline
Rep. Doris Matsui, D-Calif., and Sen. Peter Welch, D-Vt., today introduced the 340B Patients Act, AHA-supported legislation that would codify 340B providers'…
Headline
The AHA July 16 filed an amicus brief in the U.S. District Court for the District of Colorado in defense of the state’s 340B contract pharmacy law prohibiting…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
The U.S. District Court for the Eastern District of Missouri July 11 granted a motion by the state to dismiss claims by AbbVie that the state’s 340B contract…
Headline
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…